Pharmacovigilance Blog

Talk About Quality

Causality Assessment: Selection and Prioritize the Cases

This article explores how to effectively select and prioritize cases for causality assessment, with a special focus on serious and AEFI-related reports.

Bala

Read

Exploring Adverse Events

Adverse Drug Reactions: Types and Classifications Explained

In this comprehensive article, we explain the six classifieds of adverse drug reactions types, each accompanied by a brief definition.

Bala

Read

Drug safety and pharmacovigilance

🥶 Adverse Drug Reactions vs Adverse Event: The differences

In this blog, we address the common confusion between adverse reactions and adverse events. We aim to clarify the distinction between these terms that often perplex many individuals. If you are still uncertain about the difference, this blog provides the perfect opportunity to gain clarity and enhance your understanding.

Bala

Read

Our company

Designing and Implementing an Effective QMS

Designing and implementing an effective QMS is essential for ensuring consistency, compliance, and continuous improvement across any organization.

Bala

Read

Drug safety and pharmacovigilance

Subjects in Clinical Studies: Explained

In this comprehensive article, you’ll discover who the key term by subjects in clinical studies. Let’s dive in and explore.

Bala

Read

Drug safety and pharmacovigilance

Key Departments and Roles in Pharmacovigilance

This comprehensive article highlights the core departments that are essential for the smooth and effective functioning of a pharmacovigilance (PV) department.

Bala

Read

Drug safety and pharmacovigilance

Adverse Event Reporting: How to Do It Right

This article explains the importance of adverse event reporting to how to further process for effective submission reports to regulatory authorities.

Bala

Read

Exploring Adverse Events

Adverse Event Coding: Signs and Symptoms

This blog covers: Introduction Pharmacovigilance coding involves several complex and often confusing areas, including indications, adverse events, and…

Bala

Read